CalciMedica, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CalciMedica, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $25.00K, a 56.25% increase year-over-year.
- CalciMedica, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $16.00K.
- CalciMedica, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $4.00K.
- CalciMedica, Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $8.00K, a 70.37% decline year-over-year.
- CalciMedica, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $25.00K, a 25.00% increase from fiscal 2024.
- CalciMedica, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $20.00K.
- CalciMedica, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $18.00K, a 97.41% decline from fiscal 2021.
- CalciMedica, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $695.00K, a 802.60% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $25.00K 10-K · filed 2026-03-03 | |
| 2025-09-30 | $25.00K 10-Q · filed 2025-11-12 | |
| 2024-12-31 | $20.00K 10-K · filed 2026-03-03 | |
| 2024-09-30 | $16.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $4.00K 10-Q · filed 2025-11-12 | |
| 2022-12-31 | $18.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $8.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $17.00K 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $1.00K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $695.00K 10-K · filed 2023-03-09 | |
| 2021-09-30 | $27.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $495.00K 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $92.00K 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $77.00K 10-K · filed 2022-03-11 | |
| 2020-09-30 | $54.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $12.00K 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $11.00K 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $134.00K 10-K · filed 2021-03-05 | |
| 2019-09-30 | $122.00K 10-Q · filed 2020-11-12 | |
| 2019-03-31 | $9.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |